In the Media

Prof. Heidi Williams, a 2015 MacArthur Fellow, speaks with Bloomberg’s John Tozzi about why drug companies are underinvesting in long-term research. Williams explains that there are “scientifically feasible projects that aren’t getting done because there aren’t sufficient incentives."